跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS
Approved
STANDARD
CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 27, 2023
Approval ID
407e131843203630
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
407e131843203630
Drug Cima Aemps Name
CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS
Register Number
89107
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2023-10-27
Dosage Form
CÁPSULA DURA
Dose
16 mg/5 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
CANDESARTAN CILEXETILO
16 mg
AMLODIPINO BESILATO
6,94 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 27, 2023
Approval ID
407e131843203630
Type
Standard
Back to CIMA-AEMPS Approvals